These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1617708)

  • 41. Recombinant tissue plasminogen activator versus urokinase for local thrombolysis of femoropopliteal occlusions: a prospective, randomized multicenter trial.
    Mahler F; Schneider E; Hess H;
    J Endovasc Ther; 2001 Dec; 8(6):638-47. PubMed ID: 11797982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of coronary thrombolysis with plasminogen pro-activator by pretreatment with heparin.
    Susawa T; Yui Y; Hattori R; Takatsu Y; Yui N; Takahashi M; Aoyama T; Murohara Y; Shirotani M; Kawai C
    Jpn Circ J; 1988 Jan; 52(1):72-8. PubMed ID: 3129601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction.
    Ohman EM; Christenson RH; Califf RM; George BS; Samaha JK; Kereiakes DJ; Worley SJ; Wall TC; Berrios E; Sigmon KN
    Am Heart J; 1993 Oct; 126(4):819-26. PubMed ID: 8213437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
    [No Abstract]   [Full Text] [Related]  

  • 45. Safety and efficacy of extended urokinase infusion plus stent deployment for treatment of obstructed, older saphenous vein grafts.
    Denardo SJ; Morris NB; Rocha-Singh KJ; Curtis GP; Rubenson DS; Teirstein PS
    Am J Cardiol; 1995 Oct; 76(11):776-80. PubMed ID: 7572653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patency trials with reteplase (r-PA): what do they tell us?
    Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W
    Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thrombolytic therapy in acute myocardial infarction--selected recent developments.
    Bode C; Nordt TK; Runge MS
    Ann Hematol; 1994 Oct; 69(4):S35-40. PubMed ID: 7948298
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of benefit of combination thrombolytic therapy for acute myocardial infarction: a quantitative angiographic and hematologic study.
    Popma JJ; Califf RM; Ellis SG; George BS; Kereiakes DJ; Samaha JK; Worley SJ; Anderson JL; Stump D; Woodlief L
    J Am Coll Cardiol; 1992 Nov; 20(6):1305-12. PubMed ID: 1430679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjunctive intracoronary urokinase therapy during percutaneous transluminal coronary angioplasty.
    Schächinger V; Kasper W; Zeiher AM
    Am J Cardiol; 1996 Jun; 77(14):1174-8. PubMed ID: 8651091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasis.
    Flameng W; Vanhaecke J; Stump DC; Van de Werf F; Holmes W; Guenzler WA; Flohe L; Collen D
    J Am Coll Cardiol; 1986 Jul; 8(1):118-24. PubMed ID: 3086416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early detection of coronary artery patency after thrombolysis by determination of the MM creatine kinase isoforms in patients with acute myocardial infarction. PRIMI Study Group.
    Schofer J; Ress-Grigolo G; Voigt KD; Mathey DG
    Am Heart J; 1992 Apr; 123(4 Pt 1):846-53. PubMed ID: 1549991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The choice of appropriate thrombolytic agents as therapy in acute heart infarct].
    Görge G; Meyer J
    Med Klin (Munich); 1992 Feb; 87(2):70-80, 108. PubMed ID: 1542286
    [No Abstract]   [Full Text] [Related]  

  • 53. Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction.
    Van de Werf F; Vanhaecke J; de Geest H; Verstraete M; Collen D
    Circulation; 1986 Nov; 74(5):1066-70. PubMed ID: 2429783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coronary thrombolysis in man with pro-urokinase: improved efficacy with low dose urokinase.
    Kasper W; Meinertz T; Hohnloser S; Engler H; Hasler C; Rössler W; Wolf H; Welzel D; Just H; Gurewich V
    Klin Wochenschr; 1988; 66 Suppl 12():109-14. PubMed ID: 3126340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dose finding with a novel recombinant plasminogen activator (BM 06.022) in patients with acute myocardial infarction: results of the German Recombinant Plasminogen Activator Study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK).
    Neuhaus KL; von Essen R; Vogt A; Tebbe U; Rustige J; Wagner HJ; Appel KF; Stienen U; König R; Meyer-Sabellek W
    J Am Coll Cardiol; 1994 Jul; 24(1):55-60. PubMed ID: 8006283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agents.
    Collen D; Stump DC; Van de Werf F
    Am Heart J; 1986 Nov; 112(5):1083-4. PubMed ID: 3096127
    [No Abstract]   [Full Text] [Related]  

  • 57. [Efficacy and safety comparison between pro-urokinase and reteplase in the treatment of patients with acute ST elevation myocardial infarction].
    Zhang Y; Wang S; Gao CY; Liu XY; Cheng QQ; Zhang JH; Qi DD; Wang XP; Zhu ZY; Li MW; Hu DY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Sep; 49(9):866-872. PubMed ID: 34530593
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dialysis access graft thrombolysis: randomized study of pulse-spray versus continuous urokinase infusion.
    Goodwin SC; Arora LC; Razavi MK; Sayre J; McNamara TO; Yoon C
    Cardiovasc Intervent Radiol; 1998; 21(2):135-7. PubMed ID: 9502680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of lipoprotein(a) on thrombolysis.
    von Hodenberg E; Pestel E; Kreuzer J; Freitag M; Bode C
    Chem Phys Lipids; 1994 Jan; 67-68():381-5. PubMed ID: 8187238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.